China-based Meizhong Jiahe Medical Science & Technology Development Co., Ltd has completed its initial public offering (IPO) on the Hong Kong Stock Exchange, with shares priced at HKD 14.28 per share. The stock opened trading at HKD 9.8 per share and, as of the noon close, had risen to HKD 10.74 per share, giving the company a market value of HKD 7.693 billion (RMB 7.078 billion).
Meizhong Jiahe, a subsidiary of Concord Healthcare Group Co., Ltd, specializes in providing services for cancer patients and third-party medical institutions. The company initially listed on the GEM board in 2016 and was delisted in February 2018, with this IPO marking its return to the public markets.- Flcube.com
